Logo

OUR COMPANY

Building the Leading
Lysosomal Biotechnology Company

CD BioSciences is a global, innovative biotechnology company that provides effective lysosomal services and solutions to advance scientific discovery. We've developed a lysosome-targeted disease treatment platform to deliver novel drug discovery strategies for lysosomal storage disorders. This platform has the potential to help treat a range of difficult-to-treat diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Our mission is to develop lysosome-based technologies to save lives worldwide. With our years of industry experience, we are reputable for our customer-focused lysosomal engineering services, providing the highest performance in terms of safety, efficiency and reliability.

Read More

Building the Leading Lysosomal Biotechnology Company

We are unlocking the potential of the lysosome, and we can provide you with technical advice and customized solutions to achieve your goals.

OUR PRODUCTS

We offer competitive lysosomal products to support your life science research.

OUR SERVICES

Lysosomes play an important role by participating in various physiological processes within the cell. We focus on advances in lysosomal research, providing our partners with a variety of services performed by qualified experts, including structural analysis of lysosomes, lysosomalomics, lysosomal cell biology, lysosomes in autophagy, and functional analysis of lysosomes under various pathological conditions.

OUR SOLUTIONS

We combine state-of-the-art research and strategies to explore the potential of lysosomes in drug discovery and development.